Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kento Fukano

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cell Chemical Biology|May 22, 2018
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular EntryToby Passioura, Koichi Watashi, Kento Fukano, et al.
Oncotarget|May 29, 2018
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptideKei Miyakawa, Satoko Matsunaga, Yutaro Yamaoka, et al.
Frontiers in Microbiology|January 24, 2019
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into HepatocytesKento Fukano, Senko Tsukuda, Mizuki Oshima, et al.
Hepatology Communications|December 5, 2023
A versatile method to profile hepatitis B virus DNA integrationKento Fukano, Kousho Wakae, Naganori Nao, et al.
Global Health & Medicine|May 5, 2025
Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal surveyJunko S Takeuchi, Kei Yamamoto, Masami Kurokawa, et al.
Antiviral Research|June 16, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP traffickingSameh A Gad, Doaa A Abo Elwafa, Saied A Hussein, et al.
Biochemical and Biophysical Research Communications|July 20, 2023
Selective inhibition of hepatitis B virus internalization by oxysterol derivativesMizuki Oshima, Frank Stappenbeck, Hirofumi Ohashi, et al.
Biochemical and Biophysical Research Communications|May 7, 2018
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interactionWakana Saso, Senko Tsukuda, Hirofumi Ohashi, et al.
Cancer Medicine|August 21, 2020
EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancerKousho Wakae, Satoru Kondo, Hai Thanh Pham, et al.
Plos Pathogens|March 21, 2022
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitroSameh A Gad, Masaya Sugiyama, Masataka Tsuge, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cell Chemical Biology|May 22, 2018
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular EntryToby Passioura, Koichi Watashi, Kento Fukano, et al.
Oncotarget|May 29, 2018
Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptideKei Miyakawa, Satoko Matsunaga, Yutaro Yamaoka, et al.
Frontiers in Microbiology|January 24, 2019
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into HepatocytesKento Fukano, Senko Tsukuda, Mizuki Oshima, et al.
Hepatology Communications|December 5, 2023
A versatile method to profile hepatitis B virus DNA integrationKento Fukano, Kousho Wakae, Naganori Nao, et al.
Global Health & Medicine|May 5, 2025
Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: A 3-year and 9-month longitudinal surveyJunko S Takeuchi, Kei Yamamoto, Masami Kurokawa, et al.
Antiviral Research|June 16, 2025
RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP traffickingSameh A Gad, Doaa A Abo Elwafa, Saied A Hussein, et al.
Biochemical and Biophysical Research Communications|July 20, 2023
Selective inhibition of hepatitis B virus internalization by oxysterol derivativesMizuki Oshima, Frank Stappenbeck, Hirofumi Ohashi, et al.
Biochemical and Biophysical Research Communications|May 7, 2018
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interactionWakana Saso, Senko Tsukuda, Hirofumi Ohashi, et al.
Cancer Medicine|August 21, 2020
EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancerKousho Wakae, Satoru Kondo, Hai Thanh Pham, et al.
Plos Pathogens|March 21, 2022
The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitroSameh A Gad, Masaya Sugiyama, Masataka Tsuge, et al.
Pageof 3